Today: 7 February 2026
Subscribe
Browse Category

Investment Updates News 22 December 2025 - 10 January 2026

PLS Group (ASX: PLS) stock slips from fresh high — lithium prices jump, Jan 30 update looms

PLS Group (ASX: PLS) stock slips from fresh high — lithium prices jump, Jan 30 update looms

Sydney, January 10, 2026, 16:51 AEDT — Market closed PLS Group Limited (PLS.AX) shares closed down 3.1% at A$4.65 on Friday, backing away from a 52-week top of A$4.89 hit a session earlier. They traded between A$4.61 and A$4.80 on the day, with about 24.35 million shares changing hands, according to market data. (Investing.com Australia) That pullback matters now because the stock is one of Australia’s cleanest lithium proxies, and the pricing tape in China has been moving fast again. Platts assessed battery‑grade lithium carbonate — a key battery chemical — at 141,000 yuan a metric ton delivered, duty‑paid in
10 January 2026
·····
Fortescue stock slips into weekend as Rio-Glencore talks jolt miners; Jan 22 update next

Fortescue stock slips into weekend as Rio-Glencore talks jolt miners; Jan 22 update next

SYDNEY, Jan 10, 2026, 16:52 AEDT — Market closed Fortescue Ltd (FMG.AX) shares closed Friday just off, down 0.18% at A$22.71, following a turbulent start to the week for resource stocks. The Australian market is closed over the weekend, giving investors a pause before Monday brings iron ore news and deal developments back into focus. (Market Index) Rio Tinto revealed it’s in early discussions to acquire Glencore, potentially creating a mining giant through an all-share deal covering “some or all” of Glencore. The news hit Rio’s Australian shares hard, which fell 6.3%, while BHP’s stock nudged up 0.8%. Hugh Dive
10 January 2026
········
Reddit stock slides after Cantor starts coverage at Neutral and CFO sale hits filings

Reddit stock slides after Cantor starts coverage at Neutral and CFO sale hits filings

New York, Jan 9, 2026, 13:16 ET — Regular session Reddit, Inc shares fell 5.8% to $239.12 in afternoon trading on Friday, reversing an early push above $260. The move matters because Reddit stock has been priced like a fast grower, and fresh coverage is starting to draw harder lines around what that growth is worth. With results for the holiday quarter still ahead, even a “nothing’s broken” call can jolt a name trading at a premium. U.S. stocks were higher after a softer December jobs report, leaving Reddit as an outlier on the tape. The Nasdaq Composite was up
9 January 2026
···
Seatrium stock ticks up after ABS clears new 500MW offshore wind substation design

Seatrium stock ticks up after ABS clears new 500MW offshore wind substation design

Singapore, Jan 7, 2026, 15:40 SGT — Regular session Seatrium Limited (SGX:5E2) stock rose 0.45% to S$2.21 in Singapore trade on Wednesday after the American Bureau of Shipping (ABS) issued an approval in principle for its next-generation offshore wind substation design. The shares traded between S$2.20 and S$2.22, within a 52-week band of S$1.62 to S$2.60, with about 7.0 million shares changing hands by 3:39 p.m. local time. Offshore substations are the platforms that collect electricity from wind turbines and send it ashore through cables. An approval in principle, or AIP, is an early design review by a classification society;
7 January 2026
····
Immunome (IMNM) stock drops 5% as biotech slips; investors look to Jan. 14 update

Immunome (IMNM) stock drops 5% as biotech slips; investors look to Jan. 14 update

NEW YORK, Jan 5, 2026, 15:54 EST — Regular session Shares of Immunome, Inc. fell 5.3% to $19.72 in late afternoon trading on Monday, underperforming U.S. biotech peers. The SPDR S&P Biotech ETF slid 1.1% and the iShares Nasdaq Biotechnology ETF was off 0.9%. IMNM opened at $20.83 and touched $19.36, with about 1.6 million shares changing hands by 3:54 p.m. EST, according to market data. Immunome has not posted a news release since Dec. 16, when it priced a public offering of common stock, the company’s investor relations site showed. That quiet calendar can magnify day-to-day swings in small-cap
5 January 2026
·····
Axsome (AXSM) stock jumps after FDA sets April decision date for Alzheimer’s agitation filing

Axsome (AXSM) stock jumps after FDA sets April decision date for Alzheimer’s agitation filing

NEW YORK, January 1, 2026, 07:18 ET — Market closed Key points: With U.S. markets closed on Thursday for the New Year’s Day holiday, Axsome Therapeutics shares were last up 22.9% at $182.64 after the company said the FDA granted priority review for its Alzheimer’s disease agitation filing. The stock swung between $148.79 and $184.40 in Wednesday’s session. Volume was about 3.1 million shares. Axsome said the FDA accepted for filing its supplemental new drug application (sNDA) for AXS-05 in Alzheimer’s disease agitation and granted Priority Review, which shortens the agency’s target review time to about six months. The FDA
1 January 2026
····
Texas Instruments stock today: TXN flat after ReRAM licensing deal as Fed minutes land

Texas Instruments stock today: TXN flat after ReRAM licensing deal as Fed minutes land

NEW YORK, December 30, 2025, 14:44 ET — Regular session Texas Instruments Incorporated (TXN) shares were little changed on Tuesday after memory developer Weebit Nano said it had licensed its resistive random access memory, or ReRAM, technology to the chipmaker. The stock was down about 0.01% at $175.67 in afternoon trade, and TI executive Amichai Ron said the partnership would give customers access to “industry-leading NVM technology.” Weebit The announcement matters because embedded non-volatile memory — storage that keeps data when power is off — is a key building block for chips that run cars, factory equipment and other electronics
30 December 2025
······
Walmart stock today: WMT rises after-hours after CEO McMillon discloses share sale

Walmart stock today: WMT rises after-hours after CEO McMillon discloses share sale

NEW YORK, December 29, 2025, 17:50 ET — After-hours Walmart Inc (WMT.N) shares rose 0.7% to $112.53 in after-hours trading on Monday, as investors weighed an insider-sale disclosure and a defensive tilt in late-year positioning. SEC The filing matters now because markets are moving on lighter volumes into year-end, a period when single-stock headlines can draw outsized attention even if the underlying change is modest. Reuters Walmart also held up better than several retail peers as the broader market slipped. Target fell 1.4% and Costco dropped 0.6%, while Walmart was higher. A Form 4 — the SEC disclosure used to
30 December 2025
····
AST SpaceMobile (ASTS) Stock News: BlueBird 6 Commissioning Timeline, Insider Trades, and Analyst Targets Ahead of Monday’s Open

AST SpaceMobile (ASTS) Stock News: BlueBird 6 Commissioning Timeline, Insider Trades, and Analyst Targets Ahead of Monday’s Open

NEW YORK, Dec. 28, 2025, 10:06 a.m. ET — Market closed (weekend). AST SpaceMobile, Inc. (NASDAQ: ASTS) heads into the final trading week of 2025 with investors balancing a major technical milestone—its record-size BlueBird 6 satellite now in orbit—against a sharp late-week pullback and renewed debate over valuation, insider trading optics, and the pace of commercialization. With U.S. markets closed Sunday, the key question for Monday’s session (Dec. 29) is whether ASTS can stabilize after a high-volatility stretch that saw shares swing dramatically around the BlueBird 6 launch headlines. Where ASTS stands with markets closed ASTS last traded around $71.95,
28 December 2025
·····
ASX Closed on Boxing Day (26 December 2025): What to Know Before Australia’s Next Stock Market Open

ASX Closed on Boxing Day (26 December 2025): What to Know Before Australia’s Next Stock Market Open

If you’re waking up on Friday, 26 December 2025 (Boxing Day) expecting the Australian stock market (ASX) to ring the opening bell, there’s one critical detail to know first: the ASX cash market is closed today for Boxing Day.  Australian Securities Exchange That doesn’t mean investors should switch off. The market pause creates a short “information gap” where global moves in equities, commodities, FX, and rates can build up — and then reprice quickly when trading resumes. Below is what matters most before Australia’s next session, based on the latest news, market snapshots, and analyst commentary published over the past several days. Is the ASX open today, 26.12.2025?
25 December 2025
··
Gilead Sciences (GILD) Stock News Today: New Herpes Deal, TrumpRx Pricing Pact, and Fresh Wall Street Forecasts (Dec. 22, 2025)

Gilead Sciences (GILD) Stock News Today: New Herpes Deal, TrumpRx Pricing Pact, and Fresh Wall Street Forecasts (Dec. 22, 2025)

Gilead Sciences, Inc. (NASDAQ: GILD) opened the holiday-shortened week with a mix of pipeline expansion and policy-driven uncertainty—two themes that can quickly move large-cap biopharma stocks even when overall market volume is lighter than usual. On Monday, December 22, 2025, Gilead announced it has exercised its option to license Assembly Biosciences’ investigational herpes simplex virus (HSV) programs—a move that strengthens Gilead’s long-term antiviral pipeline beyond HIV. The development lands just days after Gilead joined other major drugmakers in a Trump administration “most-favored-nation” drug-pricing agreement tied to tariff relief and direct-to-consumer drug access via TrumpRx.gov. Gilead+2Gilead+2 As of the latest available
22 December 2025
·····
Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics, Inc. (NASDAQ: FOLD) stock is no longer trading like a typical biotech momentum name—at least not this week. As of December 22, 2025, the stock is hovering around $14.18, tightly anchored to the $14.50 per-share all-cash buyout BioMarin Pharmaceutical has agreed to pay. Investing.com+1 That tight range is the market’s way of saying: “We believe the deal is real, but not free money.” The remaining gap between today’s trading price and the $14.50 cash consideration reflects the time value of waiting, plus the risk (however small) that something delays or disrupts closing. Below is a full, publication-ready breakdown
22 December 2025
······
1 2 3 4

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop